Rosetta Genomics is a molecular diagnostics company advancing molecular tests based on its proprietary microRNAs, and platform technologies. Following the launch of five cancer tests since the beginning of 2009, the company is now working to develop additional tests in the cancer realm and in other fields. For more information, visit the company’s Web site: http://www.rosettagenomics.com
Let us hear your thoughts below: